vincristine  - Drug Details
📊 Estimates vincristine  Dialyzability By Different_Modalities

vincristine 

Complete Drug Information

Drug Name
vincristine 
Trade Names
Oncovin
Pregnancy Category
AU: D
Bioavailability
n/a (not reliably absorbed by the GI tract)
Routes of Administration
intravenous
Protein Binding
~44%%
Metabolism
Liver, mostly via CYP3A4 and CYP3A5
Elimination
19 to 155 hours (mean: 85 hours)
Excretion
Faeces (70–80%), urine (10–20%)
Formula
C46H56N4O10
Molar Mass
824.972
Volume of Distribution
5 L/kg

🤰 Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.